![]() |
市场调查报告书
商品编码
1847192
中国牙科植入市场:市场规模、份额和趋势分析(2025-2031年)Dental Implants Market Size, Share & Trends Analysis | China | 2025-2031 | Includes: Dental Implants, Dental Final Abutments, and 3 more |
||||||
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
2024年中国人工植牙和最终支台齿市场规模约为6.04亿美元,预计2031年将成长至超过13亿美元。
本报告涵盖人工植牙、最终支台齿、治疗计画软体和手术范本。
量化目标包括销售量、平均售价、市场规模、成长率和企业市场占有率。
它还对市场驱动因素、近期併购、公司简介、产品系列以及牙科连锁店、专科医院和独立诊所的竞争定位进行了定性分析。
中国的一项关键政策力量是基于价值的采购(VBP),其目标是透过将需求整合到符合较低单价的竞标中来降低实际支出成本。
短期影响是植入位体的 ASP 压缩,以及在较小程度上与获奖生态系相关的支台齿ASP 压缩。
中期来看,情况则更为平衡:如果竞标扩大了患者的就医管道,使诊所能够处理更多病例,那么手术量将会增加,从而有助于抵消整个市场的价格下降。
将产品组合、教育和服务与价值导向产品 (VBP) 成果相匹配的供应商,最有利于在保持市场份额的同时参与销售量成长。
市场概览
推动中国植入市场发展的三大动力是:首先是患者需求,他们追求美观、功能性,并且拥有庞大的部分牙列缺失成年人群体;其次是医疗服务规模的扩大,牙科服务机构和专科牙科医院数量迅速增长,不断扩大服务能力并增设植入牙诊疗椅;第三是政策和定价,以价值导向医疗支付(VBP)为核心,旨在降低医疗成本。
临床上,核心平台由植入骨骼的钛金属植体和连接植体与牙冠或义齿的最终支台齿组成。基于此平台,CBCT成像、电脑辅助手术和CAD/CAM支台齿在主要城市中心和学术中心的应用正在稳步推进。这些工具提高了手术精度,缩短了就诊时间,并减少了返工。然而,对于预算有限的小型诊所而言,投资扫描器、软体和提升医护人员技能的需求可能会减缓这些技术的应用。
购买人群构成至关重要。像亚瑞牙科集团、拜博牙科集团和嘉美牙科集团这样的私人牙科连锁机构正在不断扩张其网络。连锁机构可以标准化系统、协商更优惠的价格,并在所有门市实施教育培训计画。独立诊所则更注重可靠性、配件供应以及当地经销商的支援。牙科专科医院则专注于处理复杂病例,并为学员提供高级工作流程培训,包括导板手术和客製化支台齿。
市场驱动因素
辅助技术的进步。锥形束CT扫描仪和规划软体的兴起,为精确的三维模型、神经定位、鼻窦评估和引导式截骨术提供了支持。基于这些规划创建的手术范本,可以将虚拟位置转换为精确位置。这些步骤减少了手术过程中的变异性,并缩短了调整时间。虽然在中国,高昂的购置成本可能会减缓一般诊所的采购速度,但这些技术的普及应用仍将持续。
牙科服务提供者数量增加。为满足患者需求,牙科诊所的数量正在增加。连锁诊所和专科医院也在增加每日接诊量和可进行的诊疗计画范围。整合有助于改善库存管理、培训和通讯协定标准化,从而提高病例处理效率并加快数位化工具的应用。
人们对美观性的需求日益增长。植入被广泛认为是单颗牙齿缺失的最佳修復方式,外观和功能都与天然牙齿无异。随着患者寻求能够保护邻近珐琅质的固定修復方案,单颗牙齿缺失的病例正在迅速增加。这种变化推动了植入对于传统牙桥的普及。
培训和临床医生能力。透过供应商计画、学术课程和连锁研讨会主导的研讨会,植入教育的进步能够提升临床医师的信心。随着更多全科医生累积经验,诊所可以将较简单的病例纳入诊所内部处理,仅将最复杂的病例转诊给专科医生,从而增加整体植入病例量。
市场限制
基于数量的采购和定价压力。按量采购 (VBP)竞标持续对平均售价 (ASP) 构成下行压力。中标者可以获得州内或全国范围内的高市场份额,促使其降低价格。然而,单一供应商面临利润率压力,必须调整其产品组合和服务模式才能保持竞争力。
改善口腔健康。改善口腔卫生可减少重大修復手术,从而减少因人口老化而导致的多部件和全口义齿治疗数量增加,并提高每位患者的治疗价值。
费用高昂且公共保险覆盖范围有限。像植入这样的大型牙科手术不在公共保险的覆盖范围内。在中国,植入的自付费用(包括服务费)可能超过3000美元。这限制了许多家庭接受植牙,除非价值导向定价(VBP)和连锁定价能够降低总成本,否则需求将主要集中在都市区的中高所得人群中。
监管壁垒。中国的医疗设备法规要求获得本地核准,包括提供国内临床数据。外国製造商可能面临更长的註册时间。这可能会延迟其产品进入修復系统市场,并降低新型植入和支台齿设计的短期供应量。
目标市场和数据范围
量化指标:市场规模、市占率、市场预测、成长率、销售量、平均售价。
定性报告:成长驱动因素和限制因素、主要竞争对手的竞争分析和 SWOT 分析、併购、公司简介和产品系列、技术和工作流程趋势、影响定价和准入的政策环境。
时限:历史资料 2021-2024 年,预测 2025-2031 年,基准年 2024 年。
资料来源:对产业领导者的初步访谈、政府和监管资料、医院和连锁机构的投入、进出口资料、iData Research 内部资料库。
方法论收入模型为单位乘以平均售价,并透过固定单牙、牙桥和义齿应用的设定和治疗配置的采用率进行检验。
目标市场及区隔
人工植牙市场
类型:高级、超值、折扣。
形状:平行壁,锥形。
材质:钛、陶瓷或氧化锆。
治疗类型:单阶段、双阶段、即时负重。
连接类型:内部连接、外部连接、整合。
应用范围:单颗牙齿应用、多牙桥部分牙弓固定、多牙桥全牙弓固定、义齿固定。
终末支台齿市场
加工製造。包括库存零件、客製化铸件、CAD 或 CAM 设计。
材质:钛、陶瓷或氧化锆、黄金。
类型:黏接式、螺丝固位式、义齿固位式。
仪器套件市场
治疗计划软体市场
手术范本市场
竞争分析
2024年,最大的竞争对手是士卓曼集团。该品牌以其在高端植入的卓越业绩和广泛的植入相关产品组合而闻名。其价值品牌Neodent在价值型市场表现优异,并透过拓展更广泛的临床预算,巩固了其整体市场份额。持续的併购活动拓宽了产品组合的适应症和材料范围,帮助士卓曼在以价值为导向的植体和不断扩张的连锁店所主导的市场环境中保持领先地位。
2024年,欧斯汀植体在中国排名第二。该公司凭藉其与AIC网路合作的教育计画以及涵盖ET、MS和SS植入系统的产品组合而备受认可。欧斯汀不仅提供植入和支台齿产品,还提供一系列手术器械,包括再生产品、导板果冻系统和牙科椅。如此丰富的产品线有助于诊所从单一供应商采购产品,并将培训与产品使用相结合。
Envista 透过 Nobel Biocare 占据第三大市场份额。 NobelActive 和 NobelReplace 依赖强大的修復生态系统,包括 NobelProcera ASC支台齿和 OmniGrip 工具。 Envista 同时供应原厂支台齿和 CAD/CAM支台齿。儘管价格竞争依然激烈,但对于那些重视长期疗效、优质服务和清晰数位化工作流程的牙科诊所而言,Envista 仍然是首选。该公司进军再生材料领域预计将进一步完善其植入组合。
其他参与企业则在区域和地方层级展开角逐,重点关注物流、分销商关係以及为独立诊所提供的客製化支援。竞争对手的成功要素包括训练能力、可靠的供货能力、丰富的义肢产品目录,以及在基于价值的定价(VBP)规则价格分布同时支援高端和低价价格分布的能力。
科技与临床趋势
锥形束CT(CBCT)和导板手术。 CBCT规划和手术范本可提高植入精度,并减少修復体修復的需要。它们最常用于连锁医院和专科医院。小型诊所通常与外部实验室合作进行设计和导板製作,以避免大笔设备购买。
内连接和锥形设计。内连接可提供假体稳定性并控制扭力。锥形植入可在各种骨质条件下提供初期稳定性,并且只要符合临床标准,即可与即时或早期负重通讯协定相容。
材料选择。钛金属仍然是强度和骨整合的标准材料。氧化锆植入和支台齿则兼顾前牙美观和无金属偏好。当强度和美观都至关重要时,可以选择氧化锆-钛基混合支台齿设计。
传统支台齿与CAD/CAM支台齿。钛支台齿因其成本和易得性,在市场中占据主导地位。随着连锁机构和技工室不断提升扫描和铣床能力,CAD/CAM支台齿的市占率正在持续成长。客製化的基台轮廓能够改善软组织修復效果,并可实现螺丝固位修復体螺丝孔的精确对准。客製化铸造支台齿则适用于传统连接方式和特殊角度。
诊所与实验室的协作。治疗效果的品质取决于与实验室的密切合作,包括使用扫描体、设计牙龈轮廓和製定咬合计划。植入链将这些步骤标准化,并使用了解植入库和支台齿选择的内部或优选实验室。
地区
本期内容主要涉及中国。
中国植入和最终支台齿市场中最大、成长最快的机会是什么?到 2031 年,供应商将如何调整价格分布和供应商策略?
数位化如何改变日常工作流程,连锁机构和实验室不断扩展其数位化能力:CBCT、规划软体、手术范本、扫描体、CAD 或 CAM支台齿等。
哪些支台齿形式将获得市场占有率?诊所应如何平衡使用标准基台、客製化铸造基台、CAD 基台或 CAM 基台来管理软组织、咬合和螺丝孔径,同时控製成本?
牙科服务机构将如何影响采购、培训和品牌标准化?
VBP 将对诊所经济(包括病例量、椅位使用时间和返工)产生哪些实际影响?供应商如何设计套餐和教育方案来抵销利润压力?
根据适应症和具体情况,应该如何使用螺丝固位式植体和骨水泥固位式植体?骨水泥的控制和取出通讯协定如何影响长期维护?
哪些监理措施最有可能延迟产品上市?海外製造商应如何应对申报、临床证据和本地伙伴关係等阶段,以缩短产品上市时间?
哪些风险可能会减缓成长,例如更积极的平均售价压缩、小型诊所数位化普及速度缓慢,以及大型连锁机构尚未渗透的地区病患支付能力有限?
iDataResearch 的《中国人工植牙及最终支台齿市场报告》透过价格分布模型、企业市场占有率分析以及对数位化和手术流程的清晰阐述,解答了这些问题。该报告可用于预测各类别的需求、在基于价值的定价 (VBP) 环境下制定定价策略、规划产品蓝图,以及设计培训和支持方案,从而在控製成本的同时改善治疗效果。
图表清单
图表列表
调查方法
全球关税的影响
中国人工植牙和最终支台齿市场
The China dental implant and final abutment market was valued at nearly 604 million dollars in 2024. The market is forecast to grow to more than 1.3 billion dollars by 2031.
This report suite covers dental implants, final abutments, treatment planning software, and surgical guides.
Quantitative coverage includes unit sales, average selling prices, market size, growth rates, and company shares.
Qualitative coverage includes market drivers and limiters, recent mergers and acquisitions, company profiles, product portfolios, and competitive positioning across dental chains, specialist hospitals, and independent clinics.
A major policy force in China is volume-based procurement (VBP). VBP seeks to lower out-of-pocket costs by consolidating demand into tenders that reward lower unit prices.
The short-term effect is ASP compression on implant fixtures and, to a lesser extent, on abutments tied to the winning ecosystems.
The medium-term view is more balanced. As tenders expand patient access and help clinics serve more cases, procedure volumes rise, which can offset price declines at the total market level.
Vendors that align portfolios, education, and service with VBP outcomes are best positioned to defend share while participating in higher volumes.
Market Overview
China's implant market brings together three forces. First is patient demand driven by aesthetics, function, and a large base of partially edentulous adults. Second is care delivery scale, with fast-growing dental service organizations and specialist dental hospitals expanding capacity and adding implant chairs. Third is policy and pricing, centered on VBP and on the goal of lowering the total cost of care without reducing quality.
On the clinical side, the core platform is a titanium fixture placed in bone and a final abutment that connects the fixture to the crown or prosthesis. Around this platform, adoption of CBCT imaging, computer-guided surgery, and CAD or CAM abutments is steady in leading urban centers and academic hubs. These tools improve accuracy, shorten chair time, and reduce remakes. They also require investment in scanners, software, and staff skills, which can slow adoption in smaller clinics that operate on tight budgets.
The structure of the buyer base matters. Private dental chains such as Arrail Dental Group, Bybo Dental Group, and Jiamei Dental Group are expanding their networks. Chains can standardize systems, negotiate better pricing, and run education programs across locations. Independent clinics focus on reliability, availability of parts, and support from local distributors. Specialist dental hospitals handle complex cases and train residents on advanced workflows that include guided surgery and custom abutments.
Market Drivers
Improved supporting technology. The rise of CBCT scanners and planning software supports accurate 3D models, nerve mapping, sinus assessment, and guided osteotomy. Surgical guides built from these plans translate virtual positions into precise placement. These steps lower variability and reduce adjustment time during restoration. China will see continued adoption, although capital costs can delay purchases at general practices.
Growth of dental service organizations. The number of dental care organizations is growing to meet patient demand. Chains and specialist hospitals expand the number of patients per day and the range of procedures they can perform. Consolidation allows better inventory control, training, and protocol standardization, which supports higher case throughput and faster adoption of digital tools.
Demand for improved aesthetics. Implants are widely regarded as the best single-tooth replacement for natural look and function. Single-tooth cases are growing quickly as patients seek fixed solutions that preserve adjacent enamel. This shift increases implant penetration relative to conventional bridges.
Training and clinician capability. Growth in implant education through vendor programs, academic courses, and chain-led workshops improves clinician confidence. As more general practitioners gain experience, clinics can internalize straightforward cases and refer only the most complex work to specialists, which increases total implant volumes.
Market Limiters
Volume-based procurement and price pressure. VBP tenders place continued downward pressure on ASPs. Winning bids can secure high unit share within a province or nationally, which motivates lower prices. Over time, volume gains can offset value losses at the market level, but individual vendors face margin pressure and must adapt portfolios and service models to remain competitive.
Improvements in dental health. Better oral health reduces the pool of severe restorative cases. This tempers growth from aging demographics and can lower the number of multi-unit and full arch treatments that would otherwise support higher value per patient.
Costs and limited public coverage. There is no public insurance coverage for major dental procedures like implants. Out-of-pocket costs for an implant case in China can be well over 3,000 dollars including services. This limits adoption for many households and concentrates demand in middle and upper income urban segments unless VBP and chain pricing lower total costs.
Regulatory barriers. China's medical device regulation requires local approvals that can include in-country clinical data. Foreign manufacturers may face longer registration timelines. This can delay entry for restorative systems and reduce the short-term availability of new implant and abutment designs.
Market Coverage and Data Scope
Quantitative coverage. Market size, market shares, market forecasts, growth rates, units sold, and average selling prices.
Qualitative coverage. Growth drivers and limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles and product portfolios, technology and workflow trends, and the policy environment that shapes pricing and access.
Time frame. Historical data 2021 to 2024, forecasts 2025 to 2031, base year 2024.
Data sources. Primary interviews with industry leaders, government and regulatory data, hospital and chain inputs, import and export data, and the iData Research internal database.
Method note. Revenues are modeled as units multiplied by ASP, validated with adoption rates by setting and procedure mix across single-tooth, bridge, and denture securement applications.
Markets Covered and Segmentation
Dental Implants Market
Type. Premium, value, discount.
Shape. Parallel wall, tapered.
Material. Titanium, ceramic or zirconia.
Procedure type. One-stage, two-stage, immediate loading.
Connection type. Internal connection, external connection, one-piece.
Application. Single-tooth application, multi-tooth bridge partial arch securement, multi-tooth bridge full arch securement, denture securement.
Final Abutment Market
Fabrication. Stock, custom cast, CAD or CAM.
Material. Titanium, ceramic or zirconia, gold.
Type. Cement-retained, screw-retained, denture retaining.
Instrument Kit Market
Treatment Planning Software Market
Surgical Guide Market
Competitive Analysis
Straumann Group was the leading competitor in 2024. The brand has strong recognition with a record of high performance in premium implants and a broad implant-associated portfolio. The Neodent value brand has outpaced the market in the value tier, which strengthens overall share by capturing a larger range of clinical budgets. Ongoing mergers and acquisitions enhance portfolio reach across indications and materials and help Straumann defend leadership in an environment shaped by VBP and expanding chains.
Osstem Implant ranked second in China in 2024. The company has achieved strong recognition through education programs with the AIC network and a portfolio that includes the ET, MS, and SS implant systems. Osstem complements its implant and abutment lines with regenerative products, guided surgery systems, and selected operatory equipment such as dental chairs. This breadth helps clinics source from a single vendor and align training with product use.
Envista held the third largest share through Nobel Biocare. NobelActive and NobelReplace are supported by a robust prosthetic ecosystem, including the NobelProcera ASC abutment and the Omnigrip tool. Envista supplies both stock abutments and CAD or CAM abutments. Persistent price pressure shapes competitive tactics, yet the brand remains a preferred choice where clinics prioritize long-term evidence, service, and a clear digital workflow. Expansion into regenerative materials is expected to complement the implant portfolio.
Other participants compete at regional and local levels with focus on logistics, distributor relationships, and tailored support for independent clinics. Success factors across competitors include training capacity, reliable supply, broad prosthetic catalogs, and the ability to support both premium and value price points under VBP rules.
Technology and Practice Trends
CBCT and guided surgery. CBCT planning and surgical guides improve placement accuracy and reduce the need for restorative corrections. Adoption is highest in chains and in specialist hospitals. Smaller clinics often work with external labs that provide design and guide fabrication to avoid large capital purchases.
Internal connections and tapered designs. Internal connections offer prosthetic stability and torque control. Tapered implants support primary stability in a wide range of bone qualities and fit immediate or early loading protocols when clinical criteria are met.
Material use. Titanium remains the fixture standard for strength and osseointegration. Zirconia implants and zirconia abutments serve anterior esthetics and metal-free preferences. Hybrid abutment designs pair zirconia with titanium bases when strength and esthetics both matter.
Stock versus CAD or CAM abutments. Stock titanium abutments lead in volume due to cost and availability. CAD or CAM abutments gain share as chains and labs scale scanning and milling. Custom contours improve soft tissue outcomes and allow precise alignment of screw access for screw-retained restorations. Custom cast abutments remain useful for legacy connections and unusual angulations.
Clinic to lab collaboration. Outcome quality depends on tight coordination with labs for scan body use, emergence profile design, and occlusal planning. Chains standardize these steps and use internal or preferred labs that understand implant libraries and abutment options.
Geography
This edition covers China.
Where is the largest and fastest growing opportunity in China's implant and final abutment market, and how will VBP reshape price corridors and vendor strategies through 2031.
How will digitization change everyday workflows, including the pull-through for CBCT, planning software, surgical guides, scan bodies, and CAD or CAM abutments as chains and labs scale digital capacity.
Which abutment formats will gain share, and how should clinics balance stock, custom cast, and CAD or CAM to manage soft tissue, occlusion, and screw access while controlling cost.
How will dental service organizations influence procurement, training, and brand standardization, and what does this mean for premium versus value systems.
What is the practical impact of VBP on clinic economics, including case volumes, chair time, and remakes, and how can vendors design bundles and education that offset margin pressure.
What is the right mix of screw-retained and cement-retained designs by indication and setting, and how do protocols for cement control and retrievability affect long term maintenance.
Where are regulatory steps most likely to delay launches, and how should foreign manufacturers stage submissions, clinical evidence, and local partnerships to reduce time to market.
What risks could slow growth, including more aggressive ASP compression, slower digital adoption at smaller clinics, and limits on patient ability to pay in regions without strong chain penetration.
The China Dental Implant and Final Abutment Market report from iData Research answers these questions with price-tier models, company share analysis, and a clear view of digital and surgical workflows. Use it to size demand by category, set pricing strategies for VBP environments, plan product roadmaps, and design training and support programs that improve outcomes while controlling cost.
Table Of Contents
List Of Figures
List Of Charts
Research Methodology
Impact Of Global Tariffs
China Dental Implant and Final Abutment Market